Prospecting for novel plant-derived molecules of Rauvolfia serpentina as inhibitors of Aldose Reductase, a potent drug target for diabetes and its complications
- PMID: 23613832
- PMCID: PMC3629236
- DOI: 10.1371/journal.pone.0061327
Prospecting for novel plant-derived molecules of Rauvolfia serpentina as inhibitors of Aldose Reductase, a potent drug target for diabetes and its complications
Abstract
Aldose Reductase (AR) is implicated in the development of secondary complications of diabetes, providing an interesting target for therapeutic intervention. Extracts of Rauvolfia serpentina, a medicinal plant endemic to the Himalayan mountain range, have been known to be effective in alleviating diabetes and its complications. In this study, we aim to prospect for novel plant-derived inhibitors from R. serpentina and to understand structural basis of their interactions. An extensive library of R. serpentina molecules was compiled and computationally screened for inhibitory action against AR. The stability of complexes, with docked leads, was verified using molecular dynamics simulations. Two structurally distinct plant-derived leads were identified as inhibitors: indobine and indobinine. Further, using these two leads as templates, 16 more leads were identified through ligand-based screening of their structural analogs, from a small molecules database. Thus, we obtained plant-derived indole alkaloids, and their structural analogs, as potential AR inhibitors from a manually curated dataset of R. serpentina molecules. Indole alkaloids reported herein, as a novel structural class unreported hitherto, may provide better insights for designing potential AR inhibitors with improved efficacy and fewer side effects.
Conflict of interest statement
Figures












Similar articles
-
SerpentinaDB: a database of plant-derived molecules of Rauvolfia serpentina.BMC Complement Altern Med. 2015 Aug 4;15:262. doi: 10.1186/s12906-015-0683-7. BMC Complement Altern Med. 2015. PMID: 26238452 Free PMC article.
-
Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.Biomed Pharmacother. 2016 Oct;83:221-228. doi: 10.1016/j.biopha.2016.05.018. Epub 2016 Jun 30. Biomed Pharmacother. 2016. PMID: 27372406
-
Exploration of Diosmin to Control Diabetes and Its Complications-an In Vitro and In Silico Approach.Curr Comput Aided Drug Des. 2021;17(2):307-313. doi: 10.2174/1573409916666200324135734. Curr Comput Aided Drug Des. 2021. PMID: 32208122
-
Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.Mini Rev Med Chem. 2012 Apr;12(4):326-36. doi: 10.2174/138955712799829294. Mini Rev Med Chem. 2012. PMID: 22303947 Review.
-
Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.Expert Opin Investig Drugs. 2008 Apr;17(4):575-81. doi: 10.1517/13543784.17.4.575. Expert Opin Investig Drugs. 2008. PMID: 18363521 Review.
Cited by
-
Phytochemica: a platform to explore phytochemicals of medicinal plants.Database (Oxford). 2015 Aug 8;2015:bav075. doi: 10.1093/database/bav075. Print 2015. Database (Oxford). 2015. PMID: 26255307 Free PMC article.
-
Computer-aided discovery of dual-target compounds for Alzheimer's from ayurvedic medicinal plants.PLoS One. 2025 Jun 25;20(6):e0325441. doi: 10.1371/journal.pone.0325441. eCollection 2025. PLoS One. 2025. PMID: 40560959 Free PMC article.
-
Integrated network pharmacology, molecular docking and experimental validation to investigate the mechanism of tannic acid in nasopharyngeal cancer.Sci Rep. 2025 Feb 15;15(1):5645. doi: 10.1038/s41598-025-90211-z. Sci Rep. 2025. PMID: 39955364 Free PMC article.
-
Differential Network Analysis Reveals Evolutionary Complexity in Secondary Metabolism of Rauvolfia serpentina over Catharanthus roseus.Front Plant Sci. 2016 Aug 18;7:1229. doi: 10.3389/fpls.2016.01229. eCollection 2016. Front Plant Sci. 2016. PMID: 27588023 Free PMC article.
-
Computational Identification of Potential Multitarget Inhibitors of Nipah Virus by Molecular Docking and Molecular Dynamics.Microorganisms. 2022 Jun 9;10(6):1181. doi: 10.3390/microorganisms10061181. Microorganisms. 2022. PMID: 35744699 Free PMC article.
References
-
- Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos V (2009) Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Current Medicinal Chemistry 16: 734–752 doi:10.2174/092986709787458362. - DOI - PubMed
-
- Van Dieren S, Beulens J, Van der Schouw Y, Grobbee D, Neal B (2010) The global burden of diabetes and its complications: an emerging pandemic. European Journal of Cardiovascular Prevention and Rehabilitation 17 Suppl 1S3–8 doi:10.1097/01.hjr.0000368191.86614.5a. - DOI - PubMed
-
- Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813–820 doi:10.1038/414813a. - DOI - PubMed
-
- Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–1053 doi:10.2337/diacare.27.5.1047. - DOI - PubMed
-
- Kinoshita J (1990) A thirty year journey in the polyol pathway. Experimental Eye Research 50: 567–573 doi:10.1016/0014-4835(90)90096-D. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials